Last reviewed · How we verify
Quick-Acting Heart Reliever
Quick-Acting Heart Reliever is a Small molecule drug developed by Guang'anmen Hospital of China Academy of Chinese Medical Sciences. It is currently FDA-approved for Acute cardiac chest discomfort/angina-like symptoms. Also known as: Suxiao Jiuxin Pill.
Quick-Acting Heart Reliever is a traditional Chinese medicine formulation designed to rapidly relieve acute cardiac symptoms through multi-component herbal action.
The Quick-Acting Heart Reliever is a small molecule intervention used to treat conditions such as coronary artery stenosis and coronary heart disease. It is a potential alternative to isosorbide dinitrate, as indicated by a randomized double-blind placebo-controlled clinical trial (NCT01513070) conducted by Guang'anmen Hospital of China Academy of Chinese Medical Sciences.
At a glance
| Generic name | Quick-Acting Heart Reliever |
|---|---|
| Also known as | Suxiao Jiuxin Pill |
| Sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
As a marketed product from a major Chinese medical institution, this formulation likely combines multiple herbal ingredients traditionally used in Chinese medicine to address acute heart-related discomfort. The exact molecular mechanisms are not well-characterized in Western pharmacological literature, but traditional use suggests action through improving cardiac blood flow and reducing chest discomfort symptoms.
Approved indications
- Acute cardiac chest discomfort/angina-like symptoms
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Quick-Acting Heart Reliever CI brief — competitive landscape report
- Quick-Acting Heart Reliever updates RSS · CI watch RSS
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences portfolio CI
Frequently asked questions about Quick-Acting Heart Reliever
What is Quick-Acting Heart Reliever?
How does Quick-Acting Heart Reliever work?
What is Quick-Acting Heart Reliever used for?
Who makes Quick-Acting Heart Reliever?
Is Quick-Acting Heart Reliever also known as anything else?
What development phase is Quick-Acting Heart Reliever in?
Related
- Manufacturer: Guang'anmen Hospital of China Academy of Chinese Medical Sciences — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Acute cardiac chest discomfort/angina-like symptoms
- Also known as: Suxiao Jiuxin Pill
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing